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Background: Golabi, Ito, and Hall reported a family with X
linked mental retardation (XLMR), microcephaly, postnatal
growth deficiency, and other anomalies, including atrial
septal defect, in 1984.
Methods: This family was restudied as part of our ongoing
study of XLMR, but significant linkage to X chromosome
markers could not be found. Extreme short stature and
microcephaly as well as other new clinical findings were
observed. Mutations in the polyglutamine tract binding
protein 1 gene (PQBP1) have recently been reported in four
XLMR disorders (Renpenning, Hamel cerebro-palato-car-
diac, Sutherland-Haan, and Porteous syndromes) as well as
in several other families. The clinical similarity of our family to
these patients with mutations in PQBP1, particularly the
presence of microcephaly, short stature, and atrial septal
defect, prompted examination of this gene.
Results: A missense mutation in PQBP1 was identified which
changed the conserved tyrosine residue in the WW domain
at position 65 to a cysteine (p.Y65C).
Conclusions: This is the first missense mutation identified in
PQBP1 and the first mutation in the WW domain of the gene.
The WW domain has been shown to play an important role
in the regulation of transcription by interacting with the PPxY
motif found in transcription factors. The p.Y65C mutation
may affect the proper functioning of the PQBP1 protein as a
transcriptional co-activator.
K
nowledge of X chromosome gene mutations in families
with X linked mental retardation (XLMR) continues to
increase at a remarkable rate. The Greenwood-Miami
XLMR database now contains over 200 entries.1 Currently, 57
genes have been identified which encompass 77 syndromes
and at least 37 non-syndromic XLMR (MRX) families.
Mutations in 36 of the 57 known genes result only in a
syndromic phenotype, and mutations in 13 result only in a
non-syndromal phenotype. Both phenotypes have been
associated with mutations in eight genes. In 53 other
disorders and 50 MRX families, regional localisation of the
gene loci has been accomplished, but the responsible genes
have not been identified. Only 37 recognised XLMR
syndromes still await localisation or identification of a
mutation.1–3 The present report documents one more instance
in the process of gene identification among the named
XLMR syndromes with the finding that a missense mutation
in the polyglutamine tract binding protein 1 gene (PQBP1)
(p.Y65C) segregates with the clinical disorder known as
Golabi-Ito-Hall syndrome. This syndrome was reported in
19844 and restudied as part of the Greenwood-Miami XLMR
project. The missense mutation in the Golabi-Ito-Hall
syndrome is unique among the PQBP1 mutations reported
to date.
METHODS
Clinical and laboratory studies
Patients 1–3 and their pedigree numbers are the same in the
present paper and in the report by Golabi, Ito, and Hall.4
Patient 1 was examined in both studies; patient 2 was
examined only in the first study, but records from both the
facility where he was institutionalised and from autopsy were
available for the present study; patient 3 was seen only for
the present study. The findings reported by Golabi, Ito, and
Hall4 were specifically checked in the present study. Most
significant findings were consistent except for the ectodermal
abnormalities originally observed in patient 1 (dry, brittle,
sparse hair and slight nail hypoplasia). His family reported
that these were transient manifestations and they were not
observed in either affected male examined in the present
study. It is assumed they were incidental findings. A few
other reported minor facial variations were also not observed
and are not included in the summary of clinical data.
Intelligence was normal in carrier females. The present
studies were reviewed and approved by Human Subjects
Review Committees at Self Regional Healthcare and the
University of Miami.
Mutation screening
Mutation analysis of the PQBP1 gene was done by incorpora-
tion PCR SSCP (IPS) and by denaturing high performance
liquid chromatography (DHPLC). Exons 1, 2, 3, 5, and 6 were
screened by IPS and exon 4 by DHPLC.
IPS and sequence analysis
A 100 ng sample of genomic DNA was amplified in a total
volume of 10 ml containing 16 GoTaq buffer (Promega,
Madison, WI), 1 mM of each primer, 50 mM of DNTPs, and
0.05 mCi of a32P dCTP (3000 Ci/mmol; PerkinElmer Life and
Analytical Sciences, Wellesley, MA).5 GoTaq DNA polymerase
(1 U; Promega) and 0.2 mg of TaqStart antibody (Clontech,
Palo Alto, CA) were incubated at 22 C˚ for 5 min before being
added to the PCR reaction mixture. Amplification was carried
out in a PTC-200 thermocycler (MJ Research, Waltham, MA)
under the following conditions: 95 C˚ for 5 min; 30 cycles of
95 C˚ for 30s, 65 C˚ for 30 s, and 72 C˚ for 30s; 7 min extension
at 72 C˚. Following PCR, 8 ml of the IPS loading dye (95%
formamide, 10 mM NaOH, 0.25% bromophenol blue, 0.025%
xylene cyanol) was added. The samples were denatured at
96 C˚ for 5 min and resolved on a 0.56 MDE gel (FMC,
Philadelphia, PA) prepared in 0.66 TBE. The gel was run at
8 W for 16 h at room temperature. After the run the gel was
dried and the radioactive signal was visualised using
BIOMAX MS films (Eastman Kodak, Rochester, NY).
Abbreviations: DHPLC, denaturing high performance liquid
chromatography; IPS, incorporation PCR SSCP; MRX, non-syndromic
XLMR; PQBP1, polyglutamine tract binding protein 1 gene; XLMR, X
linked mental retardation
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DNA fragments exhibiting an abnormal pattern on the IPS
gel were sequenced in both directions on the MegaBACE
(Amersham Biosciences, Piscataway, NJ) using the
DYEnamic dye terminator kit (Amersham Biosciences)
according to the manufacturer’s protocol. Alignment and
analysis of the sequence was done by the Lasergene program
(DNASTAR, Madison, WI).
RESULTS
Clinical studies
A partial pedigree of the K8275 family is given in fig 1. The
complete five generation pedigree includes 55 individuals,
seven of whom were males affected with XLMR. Several died
of accidental deaths at a relatively early age; only patient 3 is
currently alive. Growth and clinical findings in three affected
males are summarised in tables 1 and 2. The term ‘‘spastic
diplegia’’ is used to indicate a predominance of spasticity in
the lower limbs, but is often accompanied by variable
spasticity in the upper limbs.
Patient IV-2
An atrial septal defect had been diagnosed at birth. The
patient was originally examined at 16 months. Examination
at 14 years of age revealed an extremely small, thin male
with minimal body fat who stood with his legs flexed. He had
no speech, but understood a few simple commands. Positive
findings included slightly upslanting palpebral fissures
(fig 2A), narrow face and triangular lower face, slightly large
mouth, a grade IV/VI systolic murmur, limited movement in
the arms, hyperactive deep tendon reflexes in the legs, and
positive Babinski signs. Scoliosis, kyphosis, and the dry,
brittle hair and nail hypoplasia described in the original
report were not observed.
At 21 years of age, because of a tremor, an MRI was
obtained, which was normal. Currently 26 years of age, the
patient is in an assisted living home and has not developed
any speech or additional neurological problems. Chromosome
studies were normal.
Patient I II-7
The original report of this patient at 28 years of age noted
growth deficiency, severe mental retardation (estimated
IQ 23), mild sensorineural hearing loss, spastic diplegia,
possible congenital heart diseases, hypospadias with normal
testes, and chronic haematuria. Subsequently, biopsy
proven chronic glomerulonephritis was documented. He
was institutionalised nearly all of his life and was not
examined by the current investigators. He had a long history
of regurgitation and aspiration and died following aspira-
tion at 42 years of age. Medical records documented short
stature, severe acne, a very large tongue, no murmur,
hyperreflexia, and flexion contractures of the right leg.
Autopsy findings included aspiration pneumonia and mini-
mal musculature in the legs; no cardiac defect was found.
The gyral pattern and gross external structure of the brain
were normal.
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Figure 1 Partial pedigree of the K8275 family and segregation of the A.G mutation. A 2% agarose gel electrophoresis of the BsrI restriction
endonuclease digestion of amplified DNA fragments from members of the Golabi-Ito-Hall family showing the segregation of the c.194A.G alteration.
The numbers below the females indicate X inactivation status. The normal males have bands of 86 and 186 bp, whereas the affected males have a
single 272 bp band. A 19 bp band which is present in all individuals has run off the gel.
Table 1 Growth in Golabi-Ito-Hall syndrome
Patient IV-2 III-7 IV-4
Age (years) Birth 1.25 14 Birth 16 42* 21
Head circumference, cm (centile) – 42 (,,3rd) 48 (,,3rd) – 51 (,3rd) – 54 (5th)
Height, cm (centile) 48.5 (20) 70 (,3rd) 129.5 (,,3rd) – 145 (,,3rd) 157 (,3rd) 144 (,,3rd)
Weight, kg (centile) 2.8 (10) 7.6 (,,3rd) 21 (,,3rd) 2.7 (10th) 35 (,3rd) 64 (25th) –
*At autopsy.
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Patient IV-4
The history of this patient was notable for a repaired atrial
septal defect and severe mental retardation. At 15 years of
age, a CT scan was performed because of seizures. This
showed bilateral calcifications of the globus pallidus and
periventricular frontal white matter. The cause of the
calcifications was not clear. At 18 years of age, other
radiological findings included mild rotatory scoliosis, mildly
thickened ribs with short clavicles, and cardiomegaly. Normal
laboratory findings included EEG, urinary mucopolysacchar-
ide excretion, plasma amino acid, and urinary organic acid
screens.
At 21 years of age, he was said to have a few words and no
history of hearing defect. On examination, he was extremely
small overall, had flexed arms, and stood with flexed legs
(fig 2B). His elbows were contracted by 15 ,˚ but his flexed
knees could be passively straightened. The head was small
and the face thin with a triangular lower face and upslanting
palpebral fissures. There was extensive dark hair on his legs
and genital region as well as similar patches elsewhere.
Brittle hair and nail hypoplasia were not noted. Testicular
size (2.563.5 cm) was normal. No intelligible speech was
heard and he did not follow simple commands.
He died at 25 years of age in a swimming pool accident.
Molecular studies
The entire PQBP1 coding region (exons 1–6) was screened for
mutations in the proband by a combination of IPS6 and
DHPLC.7 Screening of exon 3 by IPS resulted in an abnormal
pattern (data not shown). Sequencing of exon 3 from the
patient revealed that he was carrying an A to G substitution
at position 194 (c.194A.G) (data not shown). This alteration
changed the conserved tyrosine residue in the WW domain at
position 65 to a cysteine (p.Y65C). The A.G alteration
eliminated a BsrI site, making it possible to confirm co-
segregation of the c.194A.G alteration with the mental
retardation in the Golabi-Ito-Hall family (fig 1). The
segregation studies also revealed that individual IV-5 was a
carrier of the mutation (fig 1). Furthermore, the c.194A.G
mutation was not found in 334 X chromosomes from normal
males. X inactivation studies using the AR gene polymorphic
repeated sequence (ACG) showed that the four carrier
females were randomly or moderately skewed (fig 1).
DISCUSSION
Mutations in PQBP1 have recently been reported in four other
named XLMR disorders (Renpenning, Hamel cerebro-palato-
cardiac, Sutherland-Haan, and Porteous syndromes) and in
several small families with similar clinical findings.7–10 These
disorders are characterised by microcephaly, a long narrow
face, and a lean body build with short stature. Spastic
diplegia is frequent.
Use of the Greenwood-Miami XLMR database1 was
instrumental in the search for the gene causing Golabi-Ito-
Hall syndrome, as the syndrome had not been regionally
mapped on the X chromosome. The XLMR database lists 55
entries with short stature and 26 with microcephaly. Twenty
five have both microcephaly and short stature. Congenital
heart lesions, however, are uncommon in XLMR disorders.
Among the 200 listings in our XLMR database1 only eight
include any type of congenital heart disease and five of these
are not further described or defined. Three have atrial or
ventricular septal defects (PQBP1 related disorders, BCOR
(oculo-facial cardio-dental syndrome) related disorders, and
MIDAS (microphthalmia with linear skin defect) syndrome).
Since the latter two syndromes have ocular and other
distinctive clinical manifestations, PQBP1 was given priority
as a candidate gene for Golabi-Ito-Hall syndrome.
A review of the clinical and molecular findings illustrates
the differences as well as the similarities in the PQBP1 related
disorders.8–11 Two clinical differences between Golabi-Ito-Hall
syndrome and other PQPB1 related disorders are evident. The
growth of affected males with Golabi-Ito-Hall syndrome
appears to be more severely restricted than that of other
males with PQBP1 mutations; head circumference and length
are most notably restricted. As radiological and autopsy
studies did not document major CNS malformations, it is
likely that the microcephaly was a manifestation of the
overall growth deficiency.
The second difference of interest is the influence on
organogenesis. Atrial septal defects were present in two of
Figure 2 (A) Patient IV-2 at 14 years of age. (B) Patient IV-4 at
21 years of age. The lean habitus and cupped ears are evident in both,
as is the crouched stance, which was due to a combination of spasticity
and contractures. Both are markedly below the 3rd centile in height.
(Photographs are published with consent.)
PQBP1–Human/47–79
PQBP1–Mouse/47–81
PQBP1–Rat/47–81
PQBP1–Zebra fish/48–81
GLPPSWYKVFDPSCGLPYYWNADTDLVSWLSPHDP
GLPPSWYKVFDPSCGLPYYWNVETDLVSWLSPHDP
GLPPSWYKVFDPSCGLPYYWNVETDLVSWLSPHDP
SLPSNWYKVFDSACGLPYYWNVETDLVSWLSPNDP
Figure 3 Evolutionary conservation of the amino acids in the WW domain of the PQBP1 protein. A comparison of the WW domain from human,
mouse, rat, and zebra fish showing the conserved amino acids in italics. The mutated amino acid (Y) at position 65 is shaded in grey.
Table 2 Summary of clinical findings in three males with
Golabi-Ito-Hall syndrome
Clinical findings
Frequency in
patients with
truncating
mutations*
Postnatal growth deficiency 3/3
Lean body build 3/3 85%
Face
Elongation with triangular lower face 3/3 55%
Asymmetry 2/3
Upslanting palpebral fissures 3/3 39%
Cupped/prominent ears 3/3 50%
Large/prominent tongue 2/2
Micrognathia 1/3
Atrial septal defect 2/3 12.5%
Contractures and spastic diplegia 3/3
*Percentages based on summary of Stevenson et al.11
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the three affected males in the Golabi-Ito-Hall syndrome
family. Among subjects with PQBP1 mutations, 4/4 of
patients with Hamel cerebro-palato-cardiac syndrome12 and
1/4 in a recently reported family with Renpenning syndrome11
had cardiac malformations. One carrier mother had an atrial
septal defect.10 The mechanism by which mutations in PQBP1
predispose to congenital cardiac anomalies is not known at
present. In addition, small testes, which have reported in the
other PQBP1 related syndromes, were not observed in the
present family, another difference that may have a molecular
basis.8–11
Six of the seven known mutations in PQBP1 result in a
truncated protein. These affect a cell’s pre-RNA splicing
mechanism and disrupt the nuclear localisation signal.8–10 The
missense mutation in Golabi-Ito-Hall syndrome is, therefore,
of considerable interest. This mutation, p.Y65C, alters the
highly conserved hydrophobic triplet from YYW of the WW
domain to YCW (fig 3). It is known that mutations in this
triplet destroy the transcription promoting activity of RNA
polymerase II.13 The wide range of interactions of this
polymerase likely explains the unusual cardiac findings and
small testes, but the details of such possible interactions
remain unknown at this time. A more detailed comparison of
the different mutations with clinical findings in Renpenning
syndrome is provided in the reports by Kleefstra et al10 and
Stevenson et al.11 The combined information on the overall
effects on growth and on the specific effects on organogenesis
should provide an important clue for the process of
determining the exact mechanism(s) by which this specific
mutation acts.
Just as our XLMR database1 has been helpful in directing
the molecular search for this PQPB1 mutation, it should also
be of importance in guiding diagnostic molecular studies for
mutations in XLMR families, sibships with two affected
males, and even sporadic males with mental retardation.
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